277 related articles for article (PubMed ID: 25265824)
1. The effect of excipients on the release kinetics of diclofenac sodium and papaverine hydrochloride from composed tablets.
Kasperek R; Trebacz H; Zimmer Ł; Poleszak E
Acta Pol Pharm; 2014; 71(3):439-49. PubMed ID: 25265824
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous release of diclofenac sodium and papaverine hydrochloride from tablets and pellets using the flow-through cell apparatus described by dimensionless equations.
Kasperek R
Acta Pol Pharm; 2011; 68(2):261-72. PubMed ID: 21485300
[TBL] [Abstract][Full Text] [Related]
3. THE PROCESS OF MASS TRANSFER ON THE SOLID-LIQUID BOUNDARY LAYER DURING THE RELEASE OF DICLOFENAC SODIUM AND PAPAVERINE HYDROCHLORIDE FROM TABLETS IN A PADDLE APPARATUS.
Kasperek R; Zimmer L; Poleszak E
Acta Pol Pharm; 2016; 73(1):163-73. PubMed ID: 27008811
[TBL] [Abstract][Full Text] [Related]
4. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
5. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
Avachat A; Kotwal V
AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
[TBL] [Abstract][Full Text] [Related]
7. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
[TBL] [Abstract][Full Text] [Related]
8. Release kinetics of papaverine hydrochloride from tablets with different excipients.
Kasperek R; Polski A; Zimmer Ł; Poleszak E
Sci Pharm; 2014; 82(3):684-96. PubMed ID: 25853076
[TBL] [Abstract][Full Text] [Related]
9. Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.
Hussain T; Saeed T; Mumtaz AM; Javaid Z; Abbas K; Awais A; Idrees HA
Acta Pol Pharm; 2013; 70(4):749-57. PubMed ID: 23923399
[TBL] [Abstract][Full Text] [Related]
10. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
11. [Influence of polymer type on the physical properties and the release study of papaverine hydrochloride from tablets].
Kasperek R; Polski A; Sobótka-Polska K; Poleszak E
Polim Med; 2014; 44(1):5-12. PubMed ID: 24918651
[TBL] [Abstract][Full Text] [Related]
12. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
M K; Sistla R; Shastri NR
Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
[TBL] [Abstract][Full Text] [Related]
13. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
[TBL] [Abstract][Full Text] [Related]
14. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
[TBL] [Abstract][Full Text] [Related]
15. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
Obeidat WM; Alzoubi NM
Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
[TBL] [Abstract][Full Text] [Related]
16. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
Javadzadeh Y; Musaalrezaei L; Nokhodchi A
Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
[TBL] [Abstract][Full Text] [Related]
17. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride.
Yadav K; Yadav D; Srivastava AK
Drug Dev Ind Pharm; 2013 Aug; 39(8):1197-206. PubMed ID: 22803761
[TBL] [Abstract][Full Text] [Related]
19. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
Kumar CS; Reddy-Budideti KK; Battula SP; Ayyavala CS
Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
